Tactile Systems Technology (TCMD) to Post Quarterly Earnings on Monday

Tactile Systems Technology (NASDAQ:TCMD) is expected to be posting its Q2 2026 results after the market closes on Monday, August 10th. Analysts expect the company to post earnings of $0.14 per share and revenue of $85.5210 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Monday, August 10, 2026 at 5:00 PM ET.

Tactile Systems Technology Stock Performance

Shares of NASDAQ:TCMD opened at $29.50 on Friday. The firm has a market cap of $665.52 million, a PE ratio of 33.52 and a beta of 0.81. Tactile Systems Technology has a 52 week low of $12.01 and a 52 week high of $37.77. The firm’s fifty day moving average is $28.03 and its 200-day moving average is $27.09.

Insider Buying and Selling at Tactile Systems Technology

In related news, CFO Elaine M. Birkemeyer sold 4,631 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $24.49, for a total transaction of $113,413.19. Following the completion of the transaction, the chief financial officer owned 130,188 shares of the company’s stock, valued at $3,188,304.12. This trade represents a 3.43% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 2.10% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Russell Investments Group Ltd. increased its holdings in Tactile Systems Technology by 1,594.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 2,118 shares of the company’s stock worth $29,000 after buying an additional 1,993 shares in the last quarter. Quarry LP lifted its stake in Tactile Systems Technology by 302.6% during the 3rd quarter. Quarry LP now owns 2,319 shares of the company’s stock valued at $32,000 after acquiring an additional 1,743 shares during the period. Caitong International Asset Management Co. Ltd bought a new stake in shares of Tactile Systems Technology in the fourth quarter worth approximately $32,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in shares of Tactile Systems Technology during the fourth quarter valued at approximately $36,000. Finally, Global Retirement Partners LLC bought a new position in Tactile Systems Technology during the fourth quarter valued at approximately $37,000. Hedge funds and other institutional investors own 83.43% of the company’s stock.

Wall Street Analyst Weigh In

TCMD has been the topic of a number of research analyst reports. BTIG Research reissued a “buy” rating and set a $40.00 price objective on shares of Tactile Systems Technology in a research report on Thursday, May 21st. B. Riley Financial raised shares of Tactile Systems Technology from a “neutral” rating to a “buy” rating and increased their price target for the stock from $32.00 to $36.00 in a research note on Thursday, May 7th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Tactile Systems Technology in a research report on Monday, August 3rd. Four equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $38.60.

About Tactile Systems Technology

Tactile Systems Technology, Inc, headquartered in Plymouth, Minnesota, is a medical device company specializing in the design, manufacture and marketing of home-use pneumatic compression therapy systems for the treatment of lymphedema and other chronic edema-related conditions. Using proprietary software and patented pump technologies, the company’s platforms are designed to improve patient outcomes through sequential pressure treatment that promotes fluid mobilization and enhanced lymphatic function.

At the core of Tactile Systems’ product portfolio is the Flexitouch® system, a programmable pneumatic pump and garment system approved for home use, and the Aria® device, which features an intuitive touchscreen interface and advanced garment design.